Posted by Brad Siefert
The Drug Supply Chain Security Act – DSCSA (Title II, Drug Quality and Security Act, 2013) has been signed into law, with full implementation phased in over the next 10 years. The next milestone for manufacturers is November 27, 2017; the date by which Pharmaceutical manufacturers are required to print a unique product identification […]
Posted by Brad Siefert
Demand for safe packaging to combat illicit drug market rackets spread across the globe is increasing. The present market is plagued by forged pharmaceutical formulas. The soaring market size of counterfeit drugs is creating a parallel economy in the global market. The emerging threat has a rippling effect on all the stakeholders as well as […]
Posted by Brad Siefert
Counterfeit pharmaceutical drugs is a billion dollar a year industry that has put a dark stain on the healthcare industry as the lack of regulatory standards has put patients lives at risk. As a result the FDA is trying to reduce and eliminate counterfeit drugs through the DSCSA (Drug Supply Chain Security Act.) Signed by […]
Available 24hrs a day 7 days a week
Available Mon-Fri 8am-6pm PST
In addition to calling the Help Line,
please send a detailed description of your issue to:
Support
Or send a detailed description of your issue to:
Support
Or, submit an online case here:
Submit Case
Software and documentation can be downloaded from our Product and Documentation Center.
(Note: Authorization is required to access this site.)
Product &
Documentation Center
Authorization requests should be sent to:
Request access